Corline Biomedical AB: Riktad nyemission om ca 14 MSEK
20 mai 2019 12h04 HE
|
Corline Biomedical AB
Styrelsen för Corline Biomedical AB (”Corline” eller ”Bolaget”) har med stöd av årsstämmans bemyndigande från den 7 maj 2019 beslutat att emittera totalt 900 000 aktier i Bolaget med avvikelse från...
Study Shows TruGraf Blood Test Enables Non-invasive Detection of Immune Quiescent Kidney Transplant Recipients
24 oct. 2017 09h24 HE
|
Transplant Genomics Inc.
Mansfield, Oct. 24, 2017 (GLOBE NEWSWIRE) -- MANSFIELD, MA – Transplant Genomics Inc. (TGI), a molecular diagnostics company committed to improving organ transplant outcomes, announces a publication...
Postive Trial Results Of Mesoblast Cell Therapy In Patients With Diabetes And Advanced Chronic Kidney Disease
08 juin 2015 21h12 HE
|
Mesoblast
NEW YORK and MELBOURNE, Australia, June 8, 2015 (GLOBE NEWSWIRE) -- Mesoblast Limited (ASX:MSB; USOTC: MBLTY) today announced that results from the Company's Phase 2 trial in patients with diabetic...